NewGenIvf Group Limited (NIVF)

NewGenIvf Group Statistics

Total Valuation

NewGenIvf Group has a market cap or net worth of $2.48 million. The enterprise value is $4.52 million.

Market Cap	2.48M
Enterprise Value	4.52M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

NewGenIvf Group has 2.15 million shares outstanding.

Current Share Class	2.15M
Shares Outstanding	2.15M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	0.88%
Float	2.14M

Valuation Ratios

The trailing PE ratio is 1.01.

PE Ratio	1.01
Forward PE	n/a
PS Ratio	0.04
Forward PS	n/a
PB Ratio	0.27
P/TBV Ratio	0.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	7.57
EV / Sales	0.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.54.

Current Ratio	2.21
Quick Ratio	1.97
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.22

Financial Efficiency

Return on equity (ROE) is 307.05% and return on invested capital (ROIC) is -58.21%.

Return on Equity (ROE)	307.05%
Return on Assets (ROA)	-31.32%
Return on Invested Capital (ROIC)	-58.21%
Return on Capital Employed (ROCE)	-32.85%
Revenue Per Employee	$62,712
Profits Per Employee	$7,854
Employee Count	76
Asset Turnover	0.58
Inventory Turnover	32.82

Taxes

Income Tax	-486,706
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.86% in the last 52 weeks. The beta is -0.07, so NewGenIvf Group's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	-99.86%
50-Day Moving Average	1.76
200-Day Moving Average	40.71
Relative Strength Index (RSI)	31.38
Average Volume (20 Days)	935,255

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NewGenIvf Group had revenue of $4.77 million and earned $596,875 in profits. Earnings per share was $1.17.

Revenue	4.77M
Gross Profit	1.50M
Operating Income	-4.11M
Pretax Income	125,006
Net Income	596,875
EBITDA	-4.10M
EBIT	-4.11M
Earnings Per Share (EPS)	$1.17

Balance Sheet

The company has $2.70 million in cash and $4.74 million in debt, giving a net cash position of -$2.04 million or -$0.95 per share.

Cash & Cash Equivalents	2.70M
Total Debt	4.74M
Net Cash	-2.04M
Net Cash Per Share	-$0.95
Equity (Book Value)	8.79M
Book Value Per Share	4.31
Working Capital	2.79M

Cash Flow

In the last 12 months, operating cash flow was -$13.37 million and capital expenditures -$106,192, giving a free cash flow of -$13.48 million.

Operating Cash Flow	-13.37M
Capital Expenditures	-106,192
Free Cash Flow	-13.48M
FCF Per Share	-$6.26

Margins

Gross margin is 31.51%, with operating and profit margins of -86.30% and 12.52%.

Gross Margin	31.51%
Operating Margin	-86.30%
Pretax Margin	2.62%
Profit Margin	12.52%
EBITDA Margin	-85.95%
EBIT Margin	-86.30%
FCF Margin	n/a

Dividends & Yields

NewGenIvf Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	24.11%
FCF Yield	-544.31%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 4, 2025. It was a reverse split with a ratio of 1:5.

Last Split Date	Aug 4, 2025
Split Type	Reverse
Split Ratio	1:5

Scores

NewGenIvf Group has an Altman Z-Score of 0.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.13
Piotroski F-Score	3